Crestwood Advisors Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$620K Buy
2,323
+90
+4% +$24.4K 0.01% 371
2025
Q4
$560K Buy
2,233
+928
+71% +$246K 0.01% 368
2025
Q3
$375K Buy
1,305
+151
+13% +$40.5K 0.01% 414
2025
Q2
$303K Sell
1,154
-47
-4% -$11.4K 0.01% 444
2025
Q1
$280K Buy
1,201
+22
+2% +$5.34K 0.01% 440
2024
Q4
$270K Buy
1,179
+246
+26% +$56.4K 0.01% 402
2024
Q3
$209K Buy
+933
New +$205K ﹤0.01% 426
2024
Q2
Sell
-999
Closed -$218K 438
2024
Q1
$218K Sell
999
-129
-11% -$28.4K ﹤0.01% 401
2023
Q4
$256K Sell
1,128
-7
-0.6% -$1.47K 0.01% 348
2023
Q3
$228K Buy
+1,135
New +$239K 0.01% 327

Other funds holding LH

Crestwood Advisors Group's LH Position: Q1 2026 in Review

Crestwood Advisors Group increased its Labcorp (LH) stake by 4% in Q1 2026, buying an estimated $24.4K and bringing the position to 2,323 shares worth $620K. The position accounts for 0.01% of the portfolio, ranked #371.

Crestwood Advisors Group first reported a position in LH in Q3 2023 and has held it in 10 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Crestwood Advisors Group held 2,323 shares of Labcorp worth $620K as of Q1 2026.
  • Crestwood Advisors Group bought 90 Labcorp shares in Q1 2026, an estimated $24.4K.
  • Labcorp made up 0.01% of Crestwood Advisors Group's portfolio in Q1 2026, its #371 holding.
  • Crestwood Advisors Group first reported a position in Labcorp in Q3 2023 and has held it in 10 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Crestwood Advisors Group's 13F filing for Q1 2026, filed 5 May 2026.